Thanks, Greg, and good morning, everyone. Let's turn to the earnings highlights on Slide 5. Our reported fourth quarter earnings per share was $4.18 compared to $2.21 in the fourth quarter of 2022. Our reported results included a positive mark-to-market timing difference of $1.08 per share and a negative impact of $0.60 per share primarily related to acquisition and integration costs associated with our announced business combination with Viterra as well as a fixed asset impairment charge. Adjusted EPS was $3.70 in the fourth quarter versus $3.24 in the prior year. Full year 2023 earnings per share was $14.87 versus $10.51 in 2022. Adjusted full year EPS was $13.66 versus a record $13.91 in the prior year. Adjusted core segment earnings before interest and taxes, or EBIT, was $881 million in the quarter versus $804 million last year. Agribusiness had a strong close to the year. Processing results in the quarter were up $132 million, primarily related to South America, Europe and Canada, more than offsetting lower results in the U.S., which had a difficult comparison to a particularly strong prior year. Results in Asia were comparable to last year. In Merchandising, results in the quarter were down in all businesses, reflecting lower volatility. Refined and Specialty oils finished a record year with strong fourth quarter results of $212 million. Performance for the quarter was down slightly from last year as higher results in North and South America were more than offset by lower results in Europe and Asia. In Milling, improved results in the quarter were primarily driven by our South American operations, reflecting higher margins due to the combination of lower wheat costs and a more favorable pricing environment. Results in U.S. corn milling also improved. Corporate and Other improved from last year. Higher corporate expenses related to investments and growth initiatives were more than offset by positive results in our captive insurance program and Bunge Ventures. In our non-core Sugar & Bioenergy joint venture, results were lower as higher sugar prices were more than offset by lower ethanol prices. For the quarter, reported income tax expense is $219 million compared to $131 million for the prior year. The increase was primarily due to higher pre-tax income and geographic earnings mix. Adjusting for notable items and mark-to-market timing differences, the full year adjusted effective income tax rate was 23% compared to 17% for the prior year. Net interest expense of $115 million in the quarter was up compared to last year, primarily due to higher interest rates. Also impacting the quarter were foreign currency borrowings in certain countries where interest rates were high. However, the incrementally higher borrowing costs were offset with currency hedges reported within EBIT. Let's turn to Slide 6, where you can see our EPS and EBIT trends adjusted for notable items and timing differences over the past 5 years. The strong performance reflects our team's continued excellent execution in a favorable operating environment, while also delivering on a variety of initiatives to position the company for long-term growth. Slide 7 details our capital allocation. In 2023, we generated approximately $2.5 billion of adjusted funds from operations, which was up by approximately $110 million versus '22's record performance. After allocating $488 million to sustaining CapEx, which includes maintenance, environmental health and safety, we had approximately $2 billion of discretionary cash flow available. Of this amount, we paid $383 million in common dividends, invested $634 million in growth in productivity related CapEx, which is up significantly from $249 million last year, and repurchased $600 million of Bunge shares, leaving $361 million of retained cash flow for the year. Moving to Slide 8. We finished 2023 with a total CapEx spend of approximately $1.1 billion and expect to invest $1.2 billion to $1.4 billion in 2024. Our sustaining CapEx has been higher, reflecting post-pandemic catch-up and increased investments in operational and reliability where we're already seeing the benefits through reduced unplanned downtime. Also, our discretionary spend is up due to executing on our pipeline of growth projects, many of which are multiyear investments. We expect continued elevated spend in 2025 as we complete these projects. As shown on Slide 9, at year-end Readily Marketable Inventory, or RMI, exceeded our net debt by approximately $3.5 billion. This reflects our use of retained cash flow to fund working capital while reducing debt. Our adjusted leverage ratio, which reflects our adjusted net debt to adjusted EBITDA was 0.2x at the end of the fourth quarter. Slide 10 highlights our liquidity position. At year-end, all $5.7 billion of our committed credit facilities was unused and available. This provides us ample liquidity to manage our ongoing capital needs. Please turn to Slide 11. For the trailing 12 months, adjusted ROIC was 18.4%, well above our RMI adjusted weighted average cost of capital of 7.7%. ROIC was 14.3%, also well above our weighted average cost of capital of 7%. Moving to Slide 12. For the trailing 12 months, we produced discretionary cash flow of approximately $2 billion and a cash flow yield of 18.2%. Please turn to Slide 13 and our 2024 outlook. As Greg mentioned in his remarks, taking into account the current margin environment and forward curves, we expect full year 2024 adjusted EPS of approximately $9. Note that this forecast excludes any pending acquisitions that are expected to close during the year. In Agribusiness, full year results were forecasted to be down from last year's record performance, primarily due to lower results in processing where margins have compressed in most regions. Results in merchandising are forecasted to be down slightly from last year. In Refined and Specialty Oils, full year results are expected to be down from the record prior year, reflecting an environment of increased supply, particularly in the U.S. In Milling, full year results are expected to be up from last year. And in Corporate and Other full year results were also expected to be up from last year. In Non-core, full year results in our Sugar & Bioenergy joint venture are expected to be down considerably from last year reflecting lower Brazilian ethanol prices. Additionally, the company expects the following for 2024: An adjusted annual effective tax rate in the range of 21% to 25%; net interest expense in the range of $300 million to $330 million; capital expenditures in the range of $1.2 billion to $1.4 billion; and depreciation and amortization of approximately $450 million. With that, I'll turn things back over to Greg for some closing comments.